NCT04918381 2023-01-11
CellFX Treat & Resect Low-Risk BCC Feasibility Study
Pulse Biosciences, Inc.
Phase NA Completed
Clinical Trials
3 trialsNCT02159703 2019-11-21
A Single-arm Phase II Study of Post-Transoral Robotic Surgery (TORS) Alone to the Primary Tumor Site and Selective Neck Dissection (SND) Followed by Adjuvant Radiation Therapy (+/- Chemotherapy) to the Regional Nodes for Advanced Stage, Human Papilloma Virus (HPV) Positive, Oropharyngeal Cancer
Abramson Cancer Center at Penn Medicine
Phase 2 Completed
NCT00719264 2017-03-20
Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer
Novartis
Phase 2 Completed